维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="LOMBO B"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，12，6：	1
2	Ticagrelor : the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Dtez JG	2011	Core Evid2011，6，：	1
3	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
4	Ticagrelor:the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，3：	1
5	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	LOMBO B DIEZ J G	2011	Core Evid2011，6，1：	1
6	Ticagrelor: Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez J G	2011	Core Evid2011，6，：	1
7	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Jose Diez B Lombo	2011	2011 (default)2011，，：	1
8	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，：	1
9	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients w ith acute coronary syndromes显示文摘	Lombo B Diez J G	2011	Core Evid2011，6，：	1
10	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	LOMBO B DIEZ JG	2011	Core Evid2011，6，：	1
11	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Jose Diez B Lombo	2011	Core Evidence (default)2011，，：	1
12	Thickness dependencee of transport properties of doped polycrystalline tin oxide films显示文摘	BELANGER D DOBELOT J P LOMBOS B A PICKSON J I	1985	J Electrochem Soc1985，132，6：	1
13	Ticagrelor:the evidence for its clinical potentialas an oral antiplatelet treatment for the reduction of major adversecardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，：	1
14	Ticagrelor:the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes显示文摘	Lombo B Diez JG		0，，：	1
15	Ticagrelor: the evidence for its clinical po- tential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	LOMBO B DIEZ JG	2011	CoreEvid2011，6，3：	1
16	Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors显示文摘	Gill I S Kavoussi L R Lane B R Blute M L Babineau D Co- lombo J R Jr	2007	J Urol2007，178，：	1
17	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the redaction of major adverse car- diac events in patients with acute coronary syndromes 显示文摘	Lombo B Diez JG	2011	Core Evid2011，6，：	1
18	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adversecardiac events in patients with acute coronary syndromes显示文摘	Lombo B Díez JG	2011	Core Evid2011，6，：	1
19	Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes 显示文摘	LOMBO B DIEZ J G	2011	Core Evid2011，6，1：	1
20	Ticagrelor:The evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardial events in the patient with acute coronary syndromes显示文摘	Lombo B Diez JG	2011	Core Evid2011，12，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示